Skip to content

A prospective, single-center, nonrandomized, parallel-controlled clinical study of the feasibility and efficacy of ultrasound fusion imaging for thermal ablation therapy of thyroid nodules

A prospective, single-center, nonrandomized, parallel-controlled clinical study of the feasibility and efficacy of ultrasound fusion imaging for thermal ablation therapy of thyroid nodules

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097704
Enrollment
Unknown
Registered
2025-02-24
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid nodules

Interventions

Experimental group:Conventional thyroid nodule ablation on the basis of + fusion imaging
Control group:Conventional ultrasound was used for ablation guidance and evaluation of ablation efficacy

Sponsors

The Eighth Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Benign thyroid nodules with nodule diameter greater than 15mm, or malignant thyroid nodules with nodule diameter less than 20mm; (2) Ablation of thyroid nodules is planned after multidisciplinary evaluation; (3) Signed informed consent form agreeing to participate in this study.

Exclusion criteria

Exclusion criteria: ? Unable to cooperate with ablation therapy or fusion imaging examination; ? The researcher assessed that it is not appropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
The ablation efficacy of thyroid nodules;Disease-free survival period;Response evaluation criteria in solid tumors;Registration success rate;

Secondary

MeasureTime frame
Time for fusion imaging operation;Changes in intraoperative decision-making during ablation therapy using fusion imaging technology;Doctor's surgical confidence;The patient feelings;Operative time;Complications;Duration of response;Time to progression;

Countries

China

Contacts

Public ContactErjiao Xu

The Eighth Affiliated Hospital of Sun Yat-Sen University

xuerjiao@126.com+86 136 7892 5767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026